Curcumin-based anti-prostate cancer agents.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2015-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1871520615666150116102442PMID 25594891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer

  2014cited by this paper
• Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.

  2014cited by this paper
• Metabolism and permeability of curcumin in cultured Caco-2 cells.

  2013cited by this paper
• Synthesis and evaluation of curcumin-related compounds containing benzyl piperidone for their effects on human cancer cells.

  2013cited by this paper
• Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.

  2013cited by this paper
• Time for a Revision on the Role of PSA Response Rate as a Surrogate Marker for Median overall Survival in Docetaxel-based First-line Treatment for Patients with Metastatic hormone-refractory Prostate Cancer

  2013cited by this paper
• Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells.

  2013cited by this paper
• Advances in Prostate Cancer Chemoprevention: A Translational Perspective

  2013cited by this paper
• Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer

  2013cited by this paper
• Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

  2012cited by this paper
• Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.

  2012cited by this paper
• Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

  2012cited by this paper
• Design of curcumin loaded cellulose nanoparticles for prostate cancer.

  2012cited by this paper
• Synthesis and evaluation of curcumin-related compounds for anticancer activity.

  2012cited by this paper
• Plant-derived anticancer agents - curcumin in cancer prevention and treatment.

  2012cited by this paper
• Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

  2012cited by this paper
• Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment

  2011cited by this paper
• Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model.

  2011cited by this paper
• Multitargeting by curcumin as revealed by molecular interaction studies.

  2011cited by this paper
• Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.

  2011cited by this paper
• Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen

  2010cited by this paper
• Chemopreventive potential of curcumin in prostate cancer

  2010cited by this paper
• Curcumin-Induced Apoptosis in PC3 Prostate Carcinoma Cells Is Caspase-Independent and Involves Cellular Ceramide Accumulation and Damage to Mitochondria

  2010cited by this paper
• Curry spice curcumin and prostate cancer.

  2009cited by this paper
• New curcumin analogues exhibit enhanced growth‐suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells

  2009cited by this paper
• Curcumin and its analogues: Potential anticancer agents

  2009cited by this paper
• Structure-activity relationship studies of curcumin analogues.

  2009cited by this paper
• Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?

  2009cited by this paper
• Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance.

  2009cited by this paper
• Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.

  2009cited by this paper
• Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.

  2009cited by this paper
• Prostate cancer and curcumin: Add spice to your life

  2008cited by this paper
• Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

  2008cited by this paper
• Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis

  2008cited by this paper
• Curcumin as "Curecumin": from kitchen to clinic.

  2008cited by this paper
• Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature.

  2008cited by this paper
• Androgen receptor and prostate cancer

  2007cited by this paper
• NMR study of the solution structure of curcumin.

  2007cited by this paper
• Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin.

  2007cited by this paper
• Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.

  2007cited by this paper
• Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP

  2007cited by this paper
• Bioavailability of curcumin: problems and promises.

  2007cited by this paper
• Linkage of Curcumin-Induced Cell Cycle Arrest and Apoptosis by Cyclin-Dependent Kinase Inhibitor p21/WAF1/CIP1

  2007cited by this paper
• The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo

  2006cited by this paper
• Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents.

  2006cited by this paper
• Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.

  2006cited by this paper
• Secondary hormonal therapy for advanced prostate cancer.

  2006cited by this paper
• Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.

  2006cited by this paper
• Synthesis and Antitumor Activity of Some Curcumin Analogs

  2005cited by this paper
• Impact of diet on prostate cancer: a review

  2005cited by this paper
• Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells.

  2004cited by this paper
• Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.

  2004cited by this paper
• Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration

  2004cited by this paper
• Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats.

  2004cited by this paper
• 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management.

  2003cited by this paper
• Anticancer potential of curcumin: preclinical and clinical studies.

  2003cited by this paper
• Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids.

  2003cited by this paper
• Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents.

  2002cited by this paper
• Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.

  2002cited by this paper
• Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines.

  2002cited by this paper
• Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl.

  2002cited by this paper
• Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines

  2001cited by this paper
• Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

  2001cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• Recent studies on the biofunctions and biotransformations of curcumin.

  2000cited by this paper
• Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein.

  2000cited by this paper
• CREB Binding Protein Is a Coactivator for the Androgen Receptor and Mediates Cross-talk with AP-1*

  1998cited by this paper
• A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.

  1997cited by this paper
• Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP*

  1997cited by this paper
• Prostate-specific and Androgen-dependent Expression of a Novel Homeobox Gene*

  1996cited by this paper
• Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

  1996cited by this paper
• Mutual Transcriptional Interference between RelA and Androgen Receptor*

  1996cited by this paper
• Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway*

  1996cited by this paper
• Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.

  1994cited by this paper
• Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

  1994cited by this paper
• Potential anticancer activity of turmeric (Curcuma longa).

  1985cited by this paper
• LNCaP model of human prostatic carcinoma.

  1983cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper

• Targeting the Autophagy–Apoptosis Axis in Osteosarcoma: Therapeutic Potential of Biocompounds: A Review

  2026cites this paper
• Penta-1,4-dien-3-one and quinoxaline conjugates as potential anticancer agents via inhibiting EphB3/SRC/AKT axis.

  2025cites this paper
• Design, synthesis, and evaluation of cyclic C7-bridged monocarbonyl curcumin analogs containing an o-methoxy phenyl group as potential agents against gastric cancer

  2024cites this paper
• The use of curcumin in the treatment of colorectal, breast, lung, and prostate cancers: An in vivo study update

  2023cites this paper
• Synergistic effect of antiferromagnetic hematite on cuprous oxide nanocomposite: enhanced catalytic activity and reusability for N-arylation of imidazole

  2023cites this paper
• Synthetic lethality in human bladder cancer cells by curcumin via concurrent Aurora A inhibition and autophagy induction.

  2023cites this paper
• Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell

  2023cites this paper
• Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer

  2023cites this paper
• Experimental in vitro, ex vivo and in vivo models in prostate cancer research

  2022cites this paper
• Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?

  2021cites this paper
• Polyethylene glycol triggers the anti-cancer impact of curcumin nanoparticles in sw-1736 thyroid cancer cells

  2021cites this paper
• Defueling the cancer: ATP synthase as an emerging target in cancer therapy

  2021cites this paper
• Protective effect of the association of curcumin with piperine on prostatic lesions: New perspectives on BPA-induced carcinogenesis.

  2021cites this paper
• Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer

  2020cites this paper
• Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy

  2020cites this paper
• Effects of Somatostatin, Curcumin and Quercetin on the fatty acid profile of breast cancer cell membranes.

  2020cites this paper
• Drug Resistance in Cancer and Role of Nanomedicine-Based Natural Products

  2019cites this paper
• Anchorage of curcumin onto PVP enhances anti-tumor effect of curcumin

  2019cites this paper
• Schiff Bases of Tetrahydrocurcumin as Potential Anticancer Agents

  2019cites this paper
• Modulation of miR‐34a in curcumin‐induced antiproliferation of prostate cancer cells

  2019cites this paper
• Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

  2019cites this paper
• Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents

  2019cites this paper
• Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway

  2019cites this paper
• Bioactive Natural Products for the Management of Cancer: from Bench to Bedside

  2019influential citation
• Rôle du récepteur des androgènes dans les communications cellulaires au sein du cancer de la prostate

  2018cites this paper
• Synthetic resveratrol-curcumin hybrid derivative inhibits mitosis progression in estrogen positive MCF-7 breast cancer cells.

  2018cites this paper
• Polyacetal-Based Combination Therapy for the Treatment of Prostate Cancer.

  2018cites this paper
• Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.

  2018cites this paper
• Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells

  2018cites this paper
• Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility

  2018cites this paper
• Autophagy is a major mechanism for the dual effects of curcumin on renal cell carcinoma cells

  2018cites this paper
• Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms

  2018cites this paper
• Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells.

  2018cites this paper
• A comparative study on the antioxidant and immunomodulatory properties of curcumin conjugated gold nanospheres and free curcumin

  2017cites this paper
• Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy

  2017cites this paper
• Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.

  2017cites this paper
• Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.

  2017cites this paper
• Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR.

  2017cites this paper
• Prospected epigenetic moderators from natural sources and drug of class NSAIDS as effective treatment options to prostate cancer

  2017cites this paper
• Synthesis of Methotrexate Loaded Chitosan Nanoparticles and in vitro Evaluation of the Potential in Treatment of Prostate Cancer.

  2016cites this paper
• Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.

  2016cites this paper
• Synthesis of novel curcuminoids accommodating a central β-enaminone motif and their impact on cell growth and oxidative stress.

  2016cites this paper
• Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo

  2016cites this paper
• Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer.

  2016cites this paper
• eview argeting cancer stem cells and signaling pathways by hytochemicals : Novel approach for breast cancer therapy

  2016cites this paper
• Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.

  2016cites this paper
• p 53 is essential for embelin-induced apoptosis in p 53-wildtype prostate cancer cells

  2016cites this paper
• Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

  2016cites this paper
• A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.

  2015cites this paper
• The Effects of Curcumin-based Compounds on Proliferation and Cell Death in Cervical Cancer Cells.

  2015cites this paper
• Synergistic Effects of Dietary Natural Products as Anti-Prostate Cancer Agents

  2015cites this paper
• CURCUMIN: BOON FOR HUMAN BEING

  2015cites this paper
• Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.

  2015cites this paper